REFERENCES
- Tay-Kearney ML, Schwam BL, Lowder C, et al.Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996; 121:47–56.
- Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111:802–809.
- Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987; 103:137–145.
- Jabs DA, Nussenblatt RB, Rosenbaum JT;, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005; 140:509–516.
- Smith JR. HLA-B27-associated uveitis. Ophthalmol Clin North Am. 2002; 15:297–307.
- Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46:1–18.
- Verity DH, Marr JE, Ohno S, et al. Behçet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999; 54:213–220.
- Power WJ, Rodriguez A, Pedroza-seres M, et al. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998; 105:1646–1651.
- Rodriguez A, Akova YA, Pedroza-seres M, et al. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994; 101:1267–1274.